Search clinical trials for: dengue disease

Total 383641 results

National Cancer Institute (NCI)

Active, not recruiting

Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer

PRETEXT I Hepatoblastoma | PRETEXT II Hepatoblastoma | PRETEXT III Hepatoblastoma | PRETEXT IV Hepatoblastoma

United States, Canada, Puerto Rico, Australia, Japan, Brazil
Merck Sharp & Dohme LLC

Completed

Safety and Immunogenicity of Three V181 Dengue Vaccine Potencies in Adults (V181-003)

Dengue Virus | Dengue Disease

United States, Australia, Canada, Finland, Germany, Israel, Taiwan
National Institute of Allergy and Infectious Diseases...

Completed

Investigating Vector-Borne Determinants of Aedes Transmitted Arboviral Infections in Cambodia: An Observational Longitudinal Cohort Study in Children

Dengue Fever

Cambodia
Emory University
National Institute of Allergy and Infectious Diseases (NIAID)

Active, not recruiting

Quantifying the Epidemiological Impact of Targeted Indoor Residual Spraying on Aedes-borne Diseases

Dengue | Chikungunya | Zika | Aedes-borne Diseases

Mexico
Rocio Cardenas Sanchez
Göteborg University; Instituto Nacional de Salud, Colombia; Instituto Departamental... and other collaborators

Completed

Sustainable Reduction of Dengue in Colombia: Vector Breeding Site Intervention With an Insecticidal Coating

Arbovirus Infections | Vector Borne Diseases | Dengue | Chikungunya Fever | Zika

Colombia, Germany
Butantan Institute
Merck Sharp & Dohme LLC

Active, not recruiting

Clinical Bridging Study Between V181 (Dengue Quadrivalent Vaccine rDENVΔ30 [Live, Attenuated]) to Butantan Dengue Vaccine (Butantan-DV) in Healthy Adults 18 to 50 Years of Age in Brazil (V181-002)

Dengue

Brazil
National Institute of Allergy and Infectious Diseases...

Completed

Sylvatic Transmission of Zika, Dengue, and Chikungunya Viruses in Thailand and Cambodia

Dengue Fever | Chikungunya | Zika | Vector-Borne Diseases

Cambodia
State University of New York - Upstate Medical...
Walter Reed Army Institute of Research (WRAIR); U.S. Army Medical Research...

Completed

Dengue 3 Human Infection Model (DENV-3)

Dengue

United States
State University of New York - Upstate Medical...
U.S. Army Medical Research and Development Command; Janssen Pharmaceutica N...

Completed

Expansion of a Dengue-1 Live Virus Human Challenge

Dengue

United States
Takeda

Completed

Immunogenicity and Safety of Tetravalent Dengue Vaccine Candidate (TDV) in Flavivirus-Naïve and Dengue-Immune Adults

Dengue Fever

United States
University of Maryland, Baltimore
Medical Technology Enterprise Consortium (MTEC)

Completed

Dengue 4 Human Infection Model (Dengue CVD 11000; DHIM-4)

Dengue

United States
Emergent BioSolutions
National Institute of Allergy and Infectious Diseases (NIAID)

Terminated

Safety and Pharmacokinetics of UV-4B Solution Administered Orally as Multiple Ascending Doses to Healthy Subjects

Viral Infection

United States
Emergent BioSolutions
Quintiles, Inc.; Unither Virology

Completed

Study to Determine the Safety, Tolerability and Pharmacokinetics of UV-4B Solution Administered Orally in Healthy Subjects (UV)

Viral Infection

United States
Takeda

Completed

Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children

Healthy Volunteers

Philippines, Panama
GlaxoSmithKline

Terminated

This Study Will Describe the Burden of DENgue Fever Virus (DENV) Illness Among Household Members Aged 6 Months to 50 Years of Selected Communities in Latin America and Southeast Asia

Dengue | Dengue Vaccines

Philippines, Mexico
Instituto Mexicano del Seguro Social
Instituto Nacional de Salud Publica, Mexico; Centro de Investigación en Matemáticas...

Completed

Identification of Risk Determinants of Dengue Transmission Through Landscape Analysis (IRDDENGUELA)

Dengue

Mexico
Atea Pharmaceuticals, Inc.

Terminated

Study of AT-752 in Patients With Dengue Infection

Dengue Fever

Brazil, Colombia, Ecuador, India, Malaysia, Peru, Philippines, Taiwan, Thailand, Vietnam
Janssen Research & Development, LLC

Terminated

A Study of JNJ-64281802 in Participants With Confirmed Dengue Fever

Dengue

Singapore
State University of New York - Upstate Medical...
Walter Reed Army Institute of Research (WRAIR); U.S. Army Medical Research...

Active, not recruiting

Homologous Re-infection With Dengue 1 or Dengue 3

Dengue

United States
Butantan Institute

Active, not recruiting

Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue Vaccine

Dengue

Brazil
BioMérieux

Completed

Impact of Differential and Systematic Diagnosis of Dengue, Chikungunya and Malaria on Patient Management and Antibiotic Use in West Africa

Malaria | Dengue | Chikungunya

Burkina Faso, Côte D'Ivoire
Takeda

Completed

Immunogenicity and Safety of Dengue Tetravalent Vaccine (TDV) and Recombinant 9-valent Human Papillomavirus Vaccine (9vHPV) in Participants Aged ≥9 to <15 Years

Dengue Fever

Thailand
Sanofi Pasteur, a Sanofi Company

Active, not recruiting

Surveillance of Suspected Dengue Cases for Access to Care for Subjects Identified as Seronegative or Undetermined Before Receiving CYD Dengue Vaccine in Previous Clinical Studies in Colombia (CYD00082)

Dengue Fever

Colombia
Sanofi Pasteur, a Sanofi Company

Completed

Observational Study to Evaluate the Safety of CYD Tetravalent Dengue Vaccine (CYD-TDV) in Pregnant Women and Their Offsprings Inadvertently Exposed During Pregnancy

Dengue Virus Infection

Brazil
Serum Institute of India Pvt. Ltd.
PPD Australia Pty Ltd

Completed

A Phase 1 Safety Study of Dengusiil in Healthy Adults

Prevention of Dengue Fever

Australia
Bangabandhu Sheikh Mujib Medical University, Dhaka...
Institute of Technology Transfer and Innovation (ITTI)

Completed

Efficacy and Safety of Carica Papaya in Dengue Fever: A Randomised Clinical Trial

Dengue

Bangladesh
Universidad de Antioquia

Completed

Educational Intervention to Promote Control Behaviors and Prevention of Dengue

Dengue

Colombia
University of Pennsylvania
Inovio Pharmaceuticals

Completed

A Study of INO-A002 in Healthy Dengue Virus-naive Adults

Healthy Volunteers

United States
University of Malaya
Ministry of Health, Malaysia

Completed

Effectiveness Evaluation of a Dengue Self-monitoring System (DeSMoS)

Dengue

Malaysia
Foundation for Innovative New Diagnostics, Switzerland
Aga Khan University

Completed

Evaluation Study of Dengue RDTs

Dengue Fever

Pakistan
Mohamed Sayed Abdelhafez

Completed

Use of Low Dose of HCG During Ovulation Induction With CC in Women With CC Resistant PCOS

Infertility | Polycystic Ovarian Syndrome

Egypt
Centre Hospitalier Universitaire de la Réunion

Active, not recruiting

Factors Associated With Hospitalization for Dengue and Dengue Severity: Hospital-based Cohort Study on Reunion Island (DENGUE-RUN)

Dengue Fever With Warning Signs

France
Sanofi Pasteur, a Sanofi Company

Completed

Study on Prescribers' Knowledge and Understanding of Safety Messages Following Dengvaxia® Product Information Update (DNG00042)

Dengue Virus Infection

France
Oxford University Clinical Research Unit, Vietnam
Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam

Completed

Metformin in Dengue With Obesity (MeDO)

Obesity | Overweight | Dengue | Viral Infection | Metformin | Anti-inflammatory Agents

Vietnam
Phramongkutklao College of Medicine and Hospital

Completed

Effect of Montelukast in Preventing Dengue With Warning Signs in Dengue Patients

Dengue | Dengue With Warning Signs | Dengue Shock Syndrome

Thailand
University of the Philippines
World Health Organization; University of North Carolina; International Vaccine... and other collaborators

Active, not recruiting

Dengue Serostatus Study in the Philippines

Dengue | Dengue Fever | Severe Dengue | Virologically-confirmed Dengue
University of the Philippines
Sanofi Pasteur, a Sanofi Company; Research Institute for Tropical Medicine,...

Completed

Dengue Effectiveness Study in the Philippines

Dengue | Severe Dengue | Virologically Confirmed Dengue

Philippines
Atea Pharmaceuticals, Inc.

Terminated

Study of AT-752 in Healthy Subjects in a Dengue Human Challenge Model

Dengue

United States
Takeda

Completed

Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 Years

Healthy

Colombia, Singapore, Thailand, Puerto Rico
Karius, Inc.
Tribhuvan University, Nepal

Completed

Detection of Dengue Virus in Plasma of Patients in Nepal

Dengue Fever

Nepal
Beth Kirkpatrick
International Centre for Diarrhoeal Disease Research, Bangladesh

Active, not recruiting

Dengue Controlled Human Infection Model in Dhaka, Bangladesh

Dengue

Bangladesh
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive Adults

Human Immunodeficiency Virus | Dengue Fever | Dengue Hemorrhagic Fever

Brazil
National Taiwan University Hospital
Centers for Disease Control, Taiwan

Completed

Clinical Trial of the Safety and Immunogenicity of a Tetravalent Dengue Virus Vaccine Admixture TV005 in the Elderly Aged 50-70 Years in Taiwan

Dengue

Taiwan
Jazz Pharmaceuticals

Completed

An Investigation of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis Patients

Multiple Sclerosis

United Kingdom
Sanofi Pasteur, a Sanofi Company

Active, not recruiting

Cohort Event Monitoring for Dengvaxia®, CYD-TDV Dengue Vaccine

Dengue Fever | Dengue Hemorrhagic Fever

Brazil, Mexico
Emergex Vaccines Holding Ltd.
University of Lausanne Hospitals; Center for Primary Care and Public Health...

Completed

A Phase-I Study of a Nanoparticle-based Peptide Vaccine Against Dengue Virus

Dengue

Switzerland
AbViro LLC
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

A Study to Determine the Safety of AV-1, an Antibody Being Developed for Treatment of Dengue, in Healthy Volunteers

Healthy Volunteers

United States
Atea Pharmaceuticals, Inc.

Completed

Study of AT-752 in Healthy Subjects

Dengue

Australia
Takeda

Completed

Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Co-administered With an Hepatitis A Virus Vaccine

Healthy Volunteers

United Kingdom
Beijing Continent Pharmaceutical Co, Ltd.

Terminated

A Study About Safety and Efficacy of Pirfenidone to Treat Grade 2 or Grade3 Radiation-induced Lung Injury.

Radiation-induced Lung Injury

China

Search clinical trials for: dengue disease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations